China National Accord Medicines Corp. Ltd. is a healthcare company based in China with an ESG score of 20.2, indicating a medium risk level. Specializing in pharmaceutical development and manufacturing, the company distributes a wide range of medical products including Chinese patent drugs, traditional medicines, chemical preparations, antibiotics, and more. Operating through various segments including Head office, Pharmaceutical Distribution, and Retail pharmacy, China National Accord Medicines Corp. Ltd. primarily generates revenue from its Pharmaceutical Distribution segment.